In resected HCC specimen studies, the survival of individuals with HCC with a low expression of CD44 was better than that of individuals with HCC with a high expression of CD44 (mean 73.2 months vs. 44.84 months, respectively) [12]. Here, CD44 is linked to hepatocellular carcinoma.